Abstract:Background and aim: Psychiatric disorders and antidepressant usage rates have increased over the years. However, prejudice, self, and public stigma continue to impede patients from receiving appropriate treatment, especially in traditional societies. In this study, the views of first and sixth-year medical students were examined. We aimed to show the potential effect of public information and 6 years of medical education on knowledge and awareness. Method: Our target population was first and sixth-year medical… Show more
“…[ 28 29 ] The most frequent use of psychiatric drugs in the 6 th year of study may be interpreted as a use of self-medication for higher levels of depression and anxiety or related to less stigmatization toward mental health problems and their medications by this year group. [ 37 ]…”
BACKGROUND:
Previous studies have reported that medical students show high rates of depression, anxiety, and stress levels, but mixed findings were found regarding possible differences between gender and different years of medical training. This study evaluated depression, anxiety, and stress levels and psychiatric drug use in students in an Italian medical school and investigated the differences between gender and year of study.
MATERIALS AND METHODS:
This cross-sectional study included 694 medical students in their 1st (n = 286), 4th (n = 209), and 6th (n = 199) year of study. The questionnaire included demographic information, self-report questionnaires regarding depression, anxiety, and stress, and questions about psychiatric drug use. Data analysis was performed using SPSS/Ver 22 through descriptive and analytic statistics, including Mann–Whitney U-test, Fisher's exact test, and GLM two-way ANOVA.
RESULTS:
Depression, anxiety, and stress symptoms were reported by 365 (52.6%), 428 (61.7%), and 545 (78.5%) medical students, respectively. Female students in their 4th year of study reported higher depression levels than males of the same year (P = 0.004), whereas levels of anxiety were higher in 6th-year female students compared with those in their 1st and 4th years (P = 0.001; P = 0.025). Stress levels were consistently higher in females than in males for all 3 years (1st year: P = 0.041; 4th year: P < 0.001; 6th year: P = 0.004). No gender differences were found in the use of psychiatric and stimulant drugs.
CONCLUSION:
This study provides preliminary evidence suggesting the importance of planning interventions aimed at reducing emotional distress among medical students that should be targeted on gender and year of the study.
“…[ 28 29 ] The most frequent use of psychiatric drugs in the 6 th year of study may be interpreted as a use of self-medication for higher levels of depression and anxiety or related to less stigmatization toward mental health problems and their medications by this year group. [ 37 ]…”
BACKGROUND:
Previous studies have reported that medical students show high rates of depression, anxiety, and stress levels, but mixed findings were found regarding possible differences between gender and different years of medical training. This study evaluated depression, anxiety, and stress levels and psychiatric drug use in students in an Italian medical school and investigated the differences between gender and year of study.
MATERIALS AND METHODS:
This cross-sectional study included 694 medical students in their 1st (n = 286), 4th (n = 209), and 6th (n = 199) year of study. The questionnaire included demographic information, self-report questionnaires regarding depression, anxiety, and stress, and questions about psychiatric drug use. Data analysis was performed using SPSS/Ver 22 through descriptive and analytic statistics, including Mann–Whitney U-test, Fisher's exact test, and GLM two-way ANOVA.
RESULTS:
Depression, anxiety, and stress symptoms were reported by 365 (52.6%), 428 (61.7%), and 545 (78.5%) medical students, respectively. Female students in their 4th year of study reported higher depression levels than males of the same year (P = 0.004), whereas levels of anxiety were higher in 6th-year female students compared with those in their 1st and 4th years (P = 0.001; P = 0.025). Stress levels were consistently higher in females than in males for all 3 years (1st year: P = 0.041; 4th year: P < 0.001; 6th year: P = 0.004). No gender differences were found in the use of psychiatric and stimulant drugs.
CONCLUSION:
This study provides preliminary evidence suggesting the importance of planning interventions aimed at reducing emotional distress among medical students that should be targeted on gender and year of the study.
“…The DAKAS developed by Nalcakan et al focuses on the use of antidepressants and some specific perspectives on depression [ 10 ]. The scale consists of two parts: A stigma component (Section A).…”
Section: Methodsmentioning
confidence: 99%
“…Despite this increase, patients continue to face barriers to have access to appropriate care due to persistent prejudice [ 5 , 6 , 7 ], self-stigma, or public stigma [ 8 , 9 ]. According to a survey of Turkish medical students, 70.4–78.9% of respondents think that social stigmatization has a detrimental effect on adherence to antidepressants [ 10 ].…”
The prevalence of depression and anxiety has increased day by day. Prejudice, self-stigma, and public stigma, on the other hand, continue to prevent patients from seeking adequate treatment, particularly in traditional communities. In this web-based, cross-sectional study, both the presence of depression and anxiety, and the knowledge, attitude, and awareness of first- and fifth (final)-year pharmacy students were examined via an online survey. The aim was to demonstrate the potential impact of public information and five years of pharmacy school on knowledge, attitude, and awareness. Our study population consisted of first- and fifth-year pharmacy students enrolled in one faculty of pharmacy during the spring semester of 2022–2023. The Beck Depression Inventory and Beck Anxiety Scale were utilized to measure the presence of depression and anxiety, while the Depression and Antidepressant Awareness and Knowledge Scale (DAKAS) was applied to assess their knowledge, attitude, and awareness. Fifth-year participants (n = 101) exhibited noticeably fewer stigmatizing attitudes than first-year participants (n = 104) (p < 0.05). There was no statistically significant difference between the mean Beck Depression Inventory and Beck Anxiety scores in first- and fifth-year pharmacy students. Being in the fifth class (OR: 3.690; p = 0.025), being of female gender (OR: 4.653; p < 0.001), and having a relationship with someone who took a psychotropic (OR: 3.060; p = 0.008) were associated with a lower overall stigma score by multiple linear regression analysis. The students’ awareness of antidepressants and familiarity with mental health issues at the end of their pharmacy education were higher and stigmatization behavior was lower than in first-year students. The positive attitudes at the end of their training towards depression will reduce the likelihood of future pharmacists’ patients from being exposed to stigmatization, prevents the formation of an additional stress factor, and likely will improve pharmacy practices.
“…A survey of randomly selected individuals in two German cities in 2001 showed a high rate of negative beliefs about antidepressant medication: 80% of respondents believed that antidepressants were addictive, 71% believed that antidepressants had negative effects, 69% believed that antidepressant medication changed a person's personality, and 57% believed that a person does not remain themselves if they take medication for depression [1]. Although these data were collected 20 years ago, many of the same attitudes persist among patients today [2].…”
Section: The Public's Beliefs About Antidepressantsmentioning
confidence: 99%
“…These beliefs about antidepressant medication can affect how patients view their physicians, depending on the treatment approach they take [2]. Patients may have a poor opinion of physicians who prescribe antidepressants and may consider them to lack empathy, whereas they view physicians who prescribe only talk therapy as better and more empathetic professionals [1].…”
Section: The Public's Beliefs About Antidepressantsmentioning
Treatment initiation is arguably the most important step in the management of depression. It is important at this stage of treatment to establish a therapeutic partnership between physician and patient, to facilitate shared decision-making. With specific regard to pharmacotherapy, negative attitudes and beliefs about antidepressant medications are common among the general public, and these can impact on how physicians who prescribe antidepressant medication are viewed. Some of these beliefs are that antidepressants are addictive, and that they change an individual's personality. Before initiating treatment, it is important for physicians to understand the patient's attitudes towards treatment, as well as their goals for treatment, especially since the patient's goals may not be the same as the physician's. Physicians can also identify patients who may be at risk of treatment resistance-those with more severe symptoms, at risk of suicide, with higher number of lifetime depressive episodes and comorbid anxiety disorder-and to differentiate treatment resistance from overlapping
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.